carnosine has been researched along with Infections, Helicobacter in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 4 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Abdalshafy, H; Abdelazeem, B; Abuelazm, M; Ahmed, AAS; Brašić, JR; Mahmoud, A | 1 |
| Gong, M; Meng, F; Tao, H; Wang, G; Wang, W; Zhu, S | 1 |
| Chen, T; Chen, W; Jiang, H; Li, J; Li, T; Liu, Y; Sun, Y; Sun, Z; Tan, Q; Wu, D; Yuan, Z; Zhao, Y | 1 |
| Fang, JY; Ji, F; Li, JS; Li, YQ; Luo, HQ; Luo, HS; Lv, NH; Qian, JM; Ren, JL; Shi, RH; Tan, B; Xu, H; Zou, YY | 1 |
| Iishi, H; Iseki, K; Ishiguro, S; Ishihara, R; Mikuni, T; Narahara, H; Sakai, N; Tatsuta, M; Uedo, N; Yano, H | 1 |
| Hassan, M; Ikezawa, K; Kashimura, H; Mutoh, H; Nakahara, A; Sawahata, T; Suzuki, K; Tanaka, N; Watanabe, T | 1 |
| Ishii, H; Kawaguchi, C; Miura, S; Mori, M; Morita, H; Nagahashi, S; Seto, K; Suzuki, H; Suzuki, M; Yoneta, T | 1 |
| Ishii, H; Kai, A; Miura, S; Miyazawa, M; Mori, M; Seto, K; Suematsu, M; Suzuki, H; Yoneta, T | 1 |
| Kiriyama, Y; Koizumi, K; Kuwayama, H; Ohara, T; Suga, M; Suzuki, K; Takahashi, M; Takata, H | 1 |
| Annibale, B; Arpa, G; Caprioli, F; Conti, L; Corazza, GR; Di Sabatino, A; Facciotti, F; Fornasa, G; Giuffrida, P; Klersy, C; Lahner, E; Lattanzi, G; Lenti, MV; Miceli, E; Pasini, A; Paulli, M; Rescigno, M; Rovedatti, L; Spadoni, I; Travelli, C; Vanoli, A; Vecchi, M | 1 |
| Jin, M; Otaka, M; Watanabe, S | 1 |
3 review(s) available for carnosine and Infections, Helicobacter
| Article | Year |
|---|---|
Efficacy and Safety of Polaprezinc-Based Therapy versus the Standard Triple Therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Carnosine; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Zinc Compounds | 2022 |
[Polaprezinc].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Carnosine; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Urease; Zinc Compounds | 2002 |
[New therapeutic approaches to peptic ulcer using mucosal protective agents].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Bicarbonates; Carnosine; Chalcone; Chalcones; Diterpenes; Enprostil; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Mucus; Organometallic Compounds; Peptic Ulcer; Piperidines; Prostaglandins; Sucralfate | 2002 |
3 trial(s) available for carnosine and Infections, Helicobacter
| Article | Year |
|---|---|
Efficacy of quadruple regimen with polaprezinc for gastric
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Carnosine; China; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Randomized Controlled Trials as Topic; RNA, Ribosomal, 16S; Single-Blind Method; Treatment Outcome; Zinc Compounds | 2020 |
Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial.
Topics: Adult; Amoxicillin; Carnosine; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Treatment Outcome; Zinc Compounds | 2017 |
Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Carnosine; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Penicillins; Prospective Studies; Protective Agents; Zinc Compounds | 1999 |
5 other study(ies) available for carnosine and Infections, Helicobacter
| Article | Year |
|---|---|
Heat shock protein 70 is involved in polaprezinc driven cell protection against Helicobacter pylori-induced injury.
Topics: Cytoprotection; Epithelial Cells; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; HSP70 Heat-Shock Proteins; Humans; Organometallic Compounds | 2023 |
Polaprezinc attenuates Helicobacter pylori-associated gastritis in Mongolian gerbils.
Topics: Animals; Anti-Ulcer Agents; Carnosine; Chloramines; Disease Models, Animal; Gastric Mucosa; Gastritis; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Male; Organometallic Compounds; Spectrophotometry; Zinc; Zinc Compounds | 2002 |
Polaprezinc, a gastroprotective agent: attenuation of monochloramine-evoked gastric DNA fragmentation.
Topics: Analysis of Variance; Anti-Ulcer Agents; Carnosine; Cell Line; Chloramines; DNA Damage; DNA Fragmentation; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Taurine; Zinc Compounds; Zinc Sulfate | 1999 |
Polaprezinc attenuates the Helicobacter pylori-induced gastric mucosal leucocyte activation in Mongolian gerbils--a study using intravital videomicroscopy.
Topics: Animals; Anti-Ulcer Agents; Carnosine; Disease Models, Animal; Gastric Mucosa; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Inflammation; Leukocytes; Male; Organometallic Compounds; Oxidation-Reduction; Zinc Compounds | 2001 |
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis.
Topics: Aged; Carnosine; Cytokines; Female; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Mucous Membrane; Thymic Stromal Lymphopoietin; Tumor Necrosis Factor-alpha; Zinc | 2022 |